E
EGBOT
Guest
Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD
Source: Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD
HTML:
Pharmacyclics LLC today announced interim results from the ongoing Phase Ib/II PCYC-1129 study suggesting that ibrutinib (IMBRUVICA) may be a safe and effective treatment for patients with chronic graft-versus-host-disease (cGVHD) who were either refractory to steroid treatment or were steroid-dependent.
Source: Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD